Juvenile idiopathic arthritis is currently incurable, and the overall prognosis is good after treatment, but there is some possibility of recurrence and it is more difficult to stop the medication completely. Juvenile idiopathic rheumatoid arthritis refers to arthritis with unexplained swollen joints that starts under the age of 16 and lasts for more than six weeks. It is a common connective tissue disease in pediatrics, and the main goal of its treatment is to control the activity of the disease, let the disease enter into a state of inactivity or a state of low activity, so as to improve the patient’s quality of life. Idiopathic arthritis in young children is a rheumatic disease, the exact pathogenesis of which is still unclear, and common symptoms include joint pain, rash, and fever. Since there is no specific drug for the treatment of idiopathic arthritis in young children, the treatment is mainly symptomatic with anti-rheumatic drugs, non-steroidal anti-inflammatory drugs, adrenocorticotropic hormones and other drugs. There is no cure for idiopathic arthritis in young children. After treatment, most of them have a better prognosis and do not significantly affect daily life, but there is a certain possibility of recurrence, so it is more difficult to completely stop the medication. When children have joint pain, skin rash, fever and other symptoms, it is recommended to consult a doctor in time to clarify the cause of the disease, under the guidance of the doctor to carry out targeted treatment.